Accueil > Actualité
Actualite financiere : Actualite bourse

Novartis: to sell Covid treatments at zero profit

( - Swiss drugmaker Novartis said on Thursday that it will sell a portfolio of medicines for symptomatic treatment of Covid-19 at zero-profit to low-income and lower-middle-income countries.

The portfolio includes 15 medicines from its Sandoz generic-drugs business for gastro-intestinal illness, acute respiratory symptoms, pneumonia as well as septic shock, the company said.

The biosimilar and over-the-counter (OTC) drugs will be made available to governments, non-governmental organisations (NGOs) and other institutional customers in up to 79 eligible countries, it added.

"Early access to treatment for managing Covid-19 symptoms is critical to preventing healthcare system overload," Novartis said.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.